Furthermore, multiple previous studies have reported that the antifibrotic mechanisms of drugs such as theophylline, daphnetin, and donepezil in IPF involve the inhibition of Th17 differentiation and IL‐17 production [160, 162, 163]. This evidence concerns the gene IL17A and idiopathic pulmonary fibrosis.